EPIPEN Act

The EPIPEN Act, also known as Bill 118 hr 6965, is a piece of legislation currently being considered by the US Congress. The purpose of this bill is to address the rising costs of EpiPens, which are life-saving devices used to treat severe allergic reactions.

The EPIPEN Act aims to increase access to affordable EpiPens by requiring pharmaceutical companies to provide more transparency in their pricing practices. This includes disclosing the costs of producing EpiPens, as well as any price increases. The bill also seeks to promote competition in the market for EpiPens by allowing for the importation of lower-cost versions of the device.

Additionally, the EPIPEN Act includes provisions to ensure that schools and other public places have an adequate supply of EpiPens on hand in case of emergencies. This is particularly important for individuals who may experience allergic reactions while at school or in other public settings. Overall, the EPIPEN Act is aimed at addressing the high costs of EpiPens and ensuring that individuals have access to this life-saving medication when they need it. It is currently being debated in Congress, and its passage could have a significant impact on the affordability and availability of EpiPens for those who rely on them.